ストックスクリーナーアプリを入手
2.22
0.91%
0.02
プレマーケット:
2.22
前日終値:
$2.20
開ける：
$2.23
24時間の取引高:
96,775
Relative Volume:
0.56
時価総額：
$58.37M
収益：
$1.79M
当期純損益:
$-70.90M
株価収益率:
-0.1429
EPS:
-15.54
ネットキャッシュフロー:
$-34.95M
1週間 パフォーマンス:
+5.21%
1か月 パフォーマンス:
+22.65%
6か月 パフォーマンス:
-34.51%
1年 パフォーマンス:
-66.41%
1日の値動き範囲:
$2.10
$2.23
1週間の範囲:
$2.0311
$2.25
52週間の値動き範囲:
$1.26
$7.10
Senti Biosciences Inc Stock (SNTI) Company Profile
名前
Senti Biosciences Inc
セクター
電話
(650) 239-2030
住所
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
SNTI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
2.22 | 57.84M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | 開始されました | H.C. Wainwright | Buy |
| 2025-06-06 | 開始されました | Laidlaw | Buy |
| 2022-10-07 | 開始されました | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc (SNTI) 最新ニュース
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.
Senti Biosciences, Inc. to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented At the American Society of Hematology Annual Meeting 2025 - marketscreener.com
Senti Biosciences, Inc. to Host Conference Call on Updated Clinical Results for SENTI-202 Prior to ASH Annual Meeting - Quiver Quantitative
Senti Bio (Nasdaq: SNTI) to host Dec. 9 webcast on updated SENTI-202 data from ASH 2025 - Stock Titan
How Senti Biosciences Inc. stock reacts to oil pricesJuly 2025 Price Swings & Capital Efficiency Focused Strategies - Newser
Senti Bio Reports Second Quarter 2025 Financial Results and Confirms Next Data Milestone for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) Expected Q4 2025 - ADVFN
Form 8-KCurrent report - ADVFN
Check Out Senti Biosciences Inc (SNTI)’s Trade Data Rather Than the Analysts’ Views - Setenews
Senti Biosciences, Inc. (NASDAQ:SNTI) Receives $8.75 Consensus PT from Analysts - Defense World
Leerink Partners Initiates Coverage on Senti Biosciences (NASDAQ:SNTI) - Defense World
SNTI Stock Skyrockets on Initial Data From Phase I Cancer Study - MSN
Leerink Partners initiates coverage on Senti Biosciences stock with Outperform rating - Investing.com Australia
Leerink Partners Initiates Coverage of Senti Biosciences (SNTI) with Outperform Recommendation - Nasdaq
Leerink Partners initiates coverage on Senti Biosciences stock with Outperform rating By Investing.com - Investing.com South Africa
SNTI Stock Rating Update: Leerink Partners Initiates Coverage | - GuruFocus
Why Senti Biosciences Inc. stock is a must watch in 20252025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - newser.com
Is Senti Biosciences Inc. stock vulnerable to regulatory risksJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
Why Senti Biosciences Inc. stock could benefit from AI revolutionWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
Is Senti Biosciences Inc. trending in predictive chart modelsQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Combining machine learning predictions for Senti Biosciences Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - newser.com
How Senti Biosciences Inc. stock benefits from global expansionEarnings Risk Summary & Growth Focused Stock Reports - newser.com
Building trade automation scripts for Senti Biosciences Inc.2025 Volume Leaders & Weekly Momentum Picks - newser.com
Will Senti Biosciences Inc. stock recover faster than peersEarnings Recap Report & Technical Analysis for Trade Confirmation - newser.com
Is Senti Biosciences Inc. forming a reversal patternJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Will a bounce in Senti Biosciences Inc. offer an exitEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com
Bicara Therapeutics (NASDAQ:BCAX) versus Senti Biosciences (NASDAQ:SNTI) Head to Head Analysis - Defense World
Senti Biosciences Inc (SNTI) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):